D'Orazio & Associates’s Labcorp LH Stock Holding History

D'Orazio & Associates’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-74	Closed	-$18K	–	429
2021 Q3	$18K	Buy	+74	New	+$18.6K	﹤0.01%	424

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D'Orazio & Associates's LH Position: Q4 2021 in Review

D'Orazio & Associates sold out of Labcorp (LH) in Q4 2021, closing a stake of 74 shares — an estimated $18K sold.

D'Orazio & Associates first reported a position in LH in Q3 2021 and held it in 1 quarter. The position peaked at $18K in Q3 2021. 1,061 funds tracked by Wall St. Rank hold LH as of Q4 2021.

D'Orazio & Associates reported no remaining Labcorp position as of Q4 2021 after selling out during the quarter.
D'Orazio & Associates sold 74 Labcorp shares in Q4 2021, an estimated $18K.
D'Orazio & Associates first reported a position in Labcorp in Q3 2021 and held it in 1 quarter.
D'Orazio & Associates's Labcorp position peaked at $18K in Q3 2021.
1,061 funds tracked by Wall St. Rank held Labcorp as of Q4 2021.

Based on D'Orazio & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.